MISOPROSTOL AND ILLEGAL ABORTION IN FORTALEZA, BRAZIL

被引:78
作者
COELHO, HLL
TEIXEIRA, AC
SANTOS, AP
FORTE, EB
MORAIS, SM
LAVECCHIA, C
TOGNONI, G
HERXHEIMER, A
机构
[1] FED UNIV CEARA,DEPT PHARM,PREVENCAO USO INDEVIDO MEDICAMENTOS GRP,FORTALEZA,BRAZIL
[2] UNIV MILAN,IST BIOMETRIA & STAT MED,I-20122 MILAN,ITALY
[3] COCHRANE CTR,NHS RES & DEV PROGRAMME,OXFORD,ENGLAND
关键词
D O I
10.1016/0140-6736(93)91157-H
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Misoprostol, a prostaglandin E1 analogue indicated for ulcer treatment, has been widely used as an abortifacient by women in Brazil, where abortion is legal only in cases of rape or incest, or to save the woman's life. Because misoprostol is an inefficient abortifacient, many women who use it have incomplete abortions and need uterine evacuation. We reviewed the records of women admitted to the main obstetric hospital of Fortaleza, capital of Ceara state, Brazil, between January, 1990, and July, 1992, for uterine evacuation after induced abortion. The number of incomplete abortions induced by misoprostol increased substantially during the first half of 1990, and declined thereafter. Of the 593 cases in 1991, 75% were related to misoprostol, 10% to the use of other specified drugs, and 6% to unspecified drugs. For the remaining 9% the procedure used was not recorded; these included 3% in whom abortion had been induced by a clandestine abortionist. The number of uterine evacuations per month fell from 89 in August, 1990, to 62 in July, 1991, when sales of misoprostol in Ceara state were suspended. The fall continued after the sale of misoprostol ceased, to about 20 cases in December, 1991 numbers remained around this level until June, 1992, sustained by clandestine sales. The lack of access to contraception is the main reason for the large numbers of unplanned pregnancies and is a major public health issue for Brazilian women. The prohibition of abortion creates a void in which misuse of medicines is one extra complication, mainly because of the poor control of drug marketing.
引用
收藏
页码:1261 / 1263
页数:3
相关论文
共 13 条
  • [1] MISOPROSTOL, MIFEPRISTONE, AND ABORTION
    BAIRD, DT
    NORMAN, JE
    THONG, KJ
    GLASIER, AF
    [J]. LANCET, 1992, 339 (8788) : 313 - 313
  • [2] SELLING ABORTIFACIENTS OVER-THE-COUNTER IN PHARMACIES IN FORTALEZA, BRAZIL
    COELHO, HLL
    MISAGO, C
    DAFONSECA, WVC
    SOUSA, DSC
    DEARAUJO, JML
    [J]. LANCET, 1991, 338 (8761) : 247 - 247
  • [3] COELHO HLL, 1991, CIENCIA HOJE, V13, P60
  • [4] MISOPROSTOL PLUS MIFEPRISTONE
    FONSECA, W
    MISAGO, C
    KANJI, N
    [J]. LANCET, 1991, 338 (8782-3) : 1594 - 1594
  • [5] MISOPROSTOL AND CONGENITAL-MALFORMATIONS
    FONSECA, W
    ALENCAR, AJC
    MOTA, FSB
    COELHO, HLL
    [J]. LANCET, 1991, 338 (8758) : 56 - 56
  • [6] LAGUARDIA K, 1990, OBSTET GYNECOL, V75, P28
  • [7] IS WIDE AVAILABILITY OF ABORTION ESSENTIAL TO NATIONAL-POPULATION GROWTH-CONTROL PROGRAMS - EXPERIENCES OF 116 COUNTRIES
    MUMFORD, SD
    KESSEL, E
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 149 (06) : 639 - 645
  • [8] UTERINE CONTRACTILITY AND INDUCTION OF ABORTION IN EARLY-PREGNANCY BY MISOPROSTOL AND MIFEPRISTONE
    NORMAN, JE
    THONG, KJ
    BAIRD, DT
    [J]. LANCET, 1991, 338 (8777) : 1233 - 1236
  • [9] PAUMGARTTEN FJR, 1992, RISK ASSESSMENT PREN, P163
  • [10] PINOTTI JA, 1989, INT J GYNECOL OBSTET, V3, P97